Skip to main content

and
  1. Article

    Open Access

    Lymphocyte-Directed Immunomodulation Remits Thymoma-Associated Autoimmune Pneumonitis

    Thymoma presents with several autoimmune manifestations and is associated with secondary autoimmune regulator (AIRE) deficiency. Pneumonitis has recently been described as an autoimmune manifestation associate...

    Elise M. N. Ferré, Diana X. Nichols-Vinueza in Journal of Clinical Immunology (2024)

  2. Article

    Open Access

    Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy

    Diffuse pleural mesothelioma (DPM) is an aggressive therapy-resistant cancer with unique molecular features. Numerous agents have been tested, but clinically effective ones remain elusive. Herein, we propose t...

    Anand Singh, Nathanael Pruett, Shivani Dixit in Journal of Experimental & Clinical Cancer … (2023)

  3. Article

    Open Access

    A TNFR1–UBCH10 axis drives lung squamous cell carcinoma dedifferentiation and metastasis through a cell-autonomous signaling loop

    Tumor necrosis factor receptor 1 (TNFR1), encoded by TNFRSF1A, is a critical transducer of inflammatory pathways, but its physiological role in human cancer is not completely understood. Here, we observed high ex...

    Zuoxiang **ao, Gong** Shi, Sichuan **, Amit Kumar Singh in Cell Death & Disease (2022)

  4. No Access

    Article

    Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice

    Sirtuin-1 (SIRT1) is involved in various metabolic pathways, including fatty acid synthesis and gluconeogenesis in the liver. However, its role in initiation and progression of liver cancer remains unclear. St...

    Pengxiang Qiu, Weilong Hou, Haitao Wang, Kimmy Ka Wing Lei, Shaowei Wang in Oncogene (2021)

  5. No Access

    Article

    Bile acid-induced “Minority MOMP” promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1

    Barrett’s esophagus (BE) is associated with reflux and is implicated the development of esophageal adenocarcinoma (EAC). Apoptosis induces cell death through mitochondrial outer membrane permeabilization (MOMP...

    Yuan Xu, Deborah R. Surman, Laurence Diggs, Sichuan **, Shaojian Gao in Oncogene (2020)

  6. Article

    Open Access

    Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy

    Esophageal cancers accounted for nearly 16,000 deaths in 2016. The number of patients with esophageal cancers increases every year. Neoadjuvant chemoradiotherapy (nCRT) prior to esophagectomy is a standard tre...

    R. Taylor Ripley, Deborah R. Surman, Laurence P. Diggs in BMC Gastroenterology (2018)

  7. Article

    Open Access

    Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma

    Immunotherapeutic treatment strategies including adoptive cell transfer (ACT) for metastatic melanoma are capable of mediating complete and durable responses, as well as partial responses and prolonged disease...

    Nicholas D. Klemen, Paul L. Feingold, Stephanie L. Goff in Annals of Surgical Oncology (2017)

  8. No Access

    Article

    Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience

    Chronic granulomatous disease (CGD) is a genetic disorder in which phagocyte dysfunction leads to recurrent infection. Persistent pulmonary infections sometimes require thoracic surgical intervention. We revie...

    Paul L. Feingold, Humair S. Quadri, Seth M. Steinberg in Journal of Clinical Immunology (2016)

  9. No Access

    Article

    Ionic immune suppression within the tumour microenvironment limits T cell effector function

    Potassium ions released by necrotic cells in tumours impair T cell function by increasing the intracellular potassium concentration in vitro and in vivo.

    Robert Eil, Suman K. Vodnala, David Clever, Christopher A. Klebanoff in Nature (2016)

  10. No Access

    Article

    Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy

    Acromegaly resulting from the ectopic secretion of growth hormone-releasing hormone (GHRH) is rare. We present a case of acromegaly secondary to proven GHRH-secretion by a bronchial carcinoid tumor in a type 1...

    Peter W. Butler, Craig S. Cochran, Maria J. Merino, Dao M. Nguyen in Pituitary (2012)

  11. Article

    Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells

    The molecular basis of CD8+ memory is still being delineated. Gattinoni et al. show that the DNA-binding inhibitor Id3 is critical for the formation of long-lived memory.

    Yun Ji, Zoltan Pos, Mahadev Rao, Christopher A Klebanoff, Zhiya Yu in Nature Immunology (2011)

  12. Article

    Open Access

    The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone

    The standard of care for metastatic gastric cancer (MGC) is systemic chemotherapy which leads to a median survival of 6-15 months. Survival beyond 3 years is rare. For selected groups of patients with limited ...

    Sid P Kerkar, Clinton D Kemp, Austin Duffy, Udai S Kammula, David S Schrump in Trials (2009)

  13. No Access

    Article

    Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression

    The therapeutic use of T cell receptor (TCR)-transduced peripheral blood lymphocytes (PBL) targeting tumor-associated antigens is emerging as a promising investigational treatment for patients with cancer. Ini...

    Jennifer A. Wargo, Paul F. Robbins, Yong Li in Cancer Immunology, Immunotherapy (2009)

  14. Article

    Open Access

    Gene expression profiling of alveolar soft-part sarcoma (ASPS)

    Alveolar soft-part sarcoma (ASPS) is an extremely rare, highly vascular soft tissue sarcoma affecting predominantly adolescents and young adults. In an attempt to gain insight into the pathobiology of this eni...

    Luke H Stockwin, David T Vistica, Susan Kenney, David S Schrump in BMC Cancer (2009)

  15. No Access

    Article

    Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade

    Apo2L/TRAIL is actively investigated as a novel targeted agent to directly induce apoptosis of susceptible cancer cells. Apo2L/TRAIL-refractory cells can be sensitized to the cytotoxic effect of this ligand by...

    Rishindra M. Reddy, Wen-Shuz Yeow, Alex Chua, Duc M. Nguyen, Aris Baras in Apoptosis (2007)

  16. No Access

    Article

    Sequential 5-Aza 2′-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells

    cDNA arrays were used to examine gene induction in CALU-6 and H460 lung cancer cells mediated by sequential 5-aza 2′-deoxycytidine (DAC)/depsipeptide FK228 (DP) exposure in order to identify translational end ...

    Federico A Steiner, Julie A Hong, Maria R Fischette, David G Beer in Oncogene (2005)

  17. No Access

    Chapter

    Pulmonary Malignancies: Pathophysiology and Treatment

    Lung cancer is a highly lethal neoplasm, with the worldwide incidence expected to have exceeded one million cases annually by the start of this millennium. Presently, it is the most frequent cause of cancer-re...

    David S. Schrump in Principles and Practice of Geriatric Surgery (2001)

  18. No Access

    Article

    Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)

    The immune responses of 10 patients with advanced non-small cell lung cancer receiving monthly intratumoral injections of a recombinant adenovirus containing human wild-type p53 (Ad-p53) to adenovirus and transge...

    Nancy Yen, Constantin G Ioannides, Kai Xu, Stephen G Swisher in Cancer Gene Therapy (2000)